Key statistics
On Thursday, Cabaletta Bio Inc (CABA*:MEX) closed at 71.76, 0.00% above its 52-week low of 71.76, set on Aug 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 75.00 |
---|---|
High | 78.00 |
Low | 71.76 |
Bid | -- |
Offer | 79.00 |
Previous close | 81.85 |
Average volume | 0.10 |
---|---|
Shares outstanding | 48.85m |
Free float | 46.75m |
P/E (TTM) | -- |
Market cap | 212.00m USD |
EPS (TTM) | -1.92 USD |
Data delayed at least 20 minutes, as of Aug 08 2024 14:05 BST.
More ▼
Announcements
- Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024
- Cabaletta Bio to Participate in Upcoming Investor Conferences in September
- Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
- Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum
- Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201
- Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
- Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
- Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
- Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis
More ▼